Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more
Medline Inc. Class A Common Stock (MDLN) - Total Liabilities
Latest total liabilities as of September 2025: $19.74 Billion USD
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has total liabilities worth $19.74 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medline Inc. Class A Common Stock - Total Liabilities Trend (2023–2024)
This chart illustrates how Medline Inc. Class A Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medline Inc. Class A Common Stock Competitors by Total Liabilities
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Intact Financial Corporation
PINK:IFCZF
|
USA | $42.03 Billion |
|
Kimberly-Clark Corporation
NYSE:KMB
|
USA | $15.56 Billion |
|
Nutrien Ltd
NYSE:NTR
|
USA | $26.67 Billion |
|
Bank Rakyat
PINK:BKRKY
|
USA | $1776.44 Trillion |
|
Orix Corp Ads
NYSE:IX
|
USA | $13.41 Trillion |
|
ResMed Inc
NYSE:RMD
|
USA | $2.18 Billion |
|
Alcon Inc.
XETRA:2U3
|
Germany | €31.55 Billion |
|
Orange SA
XETRA:FTE
|
Germany | €69.00 Billion |
Liability Composition Analysis (2023–2024)
This chart breaks down Medline Inc. Class A Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.54 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medline Inc. Class A Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medline Inc. Class A Common Stock (2023–2024)
The table below shows the annual total liabilities of Medline Inc. Class A Common Stock from 2023 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $19.45 Billion | +1.61% |
| 2023-12-31 | $19.14 Billion | -- |